Table: Ono Pharm 6-MTH group results (IFRS)

ONO PHARMACEUTICAL

30/10/2025 03:00

Oct 30 (Reuters)- 
              Ono Pharmaceutical Co Ltd 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   6 months ended      6 months ended       Year to 
                  Sep 30, 2025        Sep 30, 2024     Mar 31, 2026 
                     LATEST             YEAR-AGO          COMPANY   
                     RESULTS             RESULT          FORECAST   
  Sales              257.14              240.34           490.00    
                   (+7.0 pct)          (-7.1 pct)       (+0.6 pct)  
  Operating           52.07               48.79            85.00    
                   (+6.7 pct)          (-49.7 pct)      (+42.3 pct) 
  Pretax              52.18               47.54            85.00    
                   (+9.7 pct)          (-52.1 pct)      (+43.3 pct) 
  Net                 40.09               37.44            67.00    
                   (+7.1 pct)          (-49.7 pct)      (+33.9 pct) 
  EPS Basic         85.33 yen           79.71 yen       142.62 yen  
  EPS Diluted       85.28 yen           79.66 yen                   
  Ann Div                               80.00 yen        80.00 yen  
  -Q2 Div           40.00 yen           40.00 yen                   
  -Q4 Div                               40.00 yen        40.00 yen  
 
  NOTE - Ono Pharmaceutical Co Ltd. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4528.T